Seeking Alpha

Eli Lilly & Co. (LLY)

()

News & PR
Market Currents

Buzz
Twitter: LLY

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Barron's Calls a Bottom
Mar 8 • SA Editor Eli Hoffmann • BMY, DIA, GIS • 79 Comments
12 Attractive Companies That Also Pay a Dividend
Mar 1 • Value Expectations • BMY, CAT, CHH • 35 Comments
The 20 Highest Yielding Dividend Aristocrats
Jun 12, 2008 • Dividend Growth Investor • AVY, BAC, BBT • 34 Comments
8 Dividend Stocks with Wide Moats
Oct 21 • Dividends4Life • ABT, JNJ, KO • 33 Comments
Barron's: Best Dividend Plays for 2009
Feb 15 • SA Editor Rachael Granby • BMY, EQ, ETN • 25 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Sep 11 • Justin M. Hall • ALTH, ARIA, ARQL • 23 Comments
Wall Street Breakfast: Must-Know News
Sep 29, 2008 • SA Editor Eli Hoffmann • AIG, AXA, AZ • 22 Comments
Pharmaceutical Facts Investors Should Know
May 29, 2008 • Mark J. Perry • ABT, AMGN, JNJ • 21 Comments
Cash Mirages: S&P 500 Companies with Large Balances But Not So Visible Liabilities
Mar 18 • Alan Brochstein • LLY, PG, VZ • 19 Comments
Wall Street Breakfast: Must-Know News
Apr 20 • SA Editor Rachael Granby • AIG, BAC, COP • 19 Comments
Wall Street Breakfast: Must-Know News
Jan 15 • SA Editor Rachael Granby • AAPL, ASML, BAC • 19 Comments
Wall Street Breakfast: Must-Know News
Aug 18 • SA Editor Rachael Granby • A, AIG, AMCN • 17 Comments
Wall Street Breakfast: Must-Know News
Mar 31 • SA Editor Rachael Granby • BAC, BCS, C • 17 Comments
Time to Get Conservative? 50 Ideas for a Summer Sell-Off
Aug 3 • Marco Hickey • AAPL, ABT, AMGN • 16 Comments
One Page Annotated WSJ Summary, June 6th
Jun 6, 2006 • David Jackson • AMD, BPO, CL • 16 Comments
Why It's Not 1982 Again, Part 2
Sep 24 • William M. Wright • LLY, VZ • 16 Comments
Wall Street Breakfast: Must-Know News
Aug 31 • SA Editor Rachael Granby • AIG, AZN, BHI • 16 Comments
Wall Street Breakfast: Must-Know News
Jun 12 • SA Editor Rachael Granby • BAC, BCS, BLK • 15 Comments
Big Pharma: Where's the Risk Management?
Jul 7 • Thomas Barnard • GNBT, LLY, NVO • 15 Comments
BioMS: Hype or Hope?
Jul 13 • Richard Sater • BAYRY.PK, BIIB, BOMSF.PK • 14 Comments
Pharmaceutical Dollar Rationing by Results
Jul 1 • Michael Steinberg • BMY, IYH, LLY • 14 Comments
Wall Street Breakfast: Must-Know News
Aug 1, 2008 • SA Editor Eli Hoffmann • ANR, CEMJQ.PK, CHK • 14 Comments
The Imperatives of Healthcare Reform
May 27 • James Rickman • AZN, HUM, JNJ • 13 Comments
Dividend Aristocrats: 3 to Watch
Oct 20 • Avi Morris • DIA, GE, IMCL • 13 Comments
Wall Street Breakfast: Must-Know News
Jul 22 • SA Editor Rachael Granby • AAI, AAPL, AMD • 13 Comments
Mid-Year Picks and Pans From Barron's Roundtable Part III
Jun 15, 2008 • SA Editor Eli Hoffmann • BK, DBC, DHI • 13 Comments
Wall Street Breakfast: Must-Know News
Jul 24, 2008 • SA Editor Eli Hoffmann • ABC, AFL, AMP • 12 Comments
Investing in High-Yield Dividend Stocks
Oct 13 • Dividends4Life • BKH, CCBG, CINF • 12 Comments
Cash Analysis: Wal-Mart, Lilly, Verizon Not Quite So Rich
Mar 17 • Alan Brochstein • AAPL, ABT, ADM • 11 Comments
Wall Street Breakfast: Must-Know News
Sep 15 • SA Editors • BAC, BIIB, C • 11 Comments

Eli Lilly & Co. (LLY)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers